Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

• Schizophrenia Update


In this video activity, Troy A. Moore describes the new atypical antipsychotics available in the US, the new evidence in treating first episode schizoprhrenia and the new evidence supporting augmentation strategies in treatment-resistant schizophrenia.
 
 
 
The lecture was originally recorded at The University of Texas at Austin College of Pharmacy's annual Psychiatric Pharmacotherapy Update.
 
 
 
       
Scroll down for full video.

Program Design: 
This course is presented in a lecture format, available via MP4 files, and is accompanied by PDFs of the presenter's PowerPoint slides. A post-test and program evaluation will be completed after reviewing the presentation. The post-test and evaluation must be completed BEFORE March 2019.
 
Note:
The video and PDF documents were developed to work on most computers, tablets, and smartphones.
 

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

 
ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.100 CEUs (1.00 contact hour) of continuing education credit.  In order to receive 1.00 contact hours of CE credit, the participant must watch the videos in its entirety, complete the online post-tests, and complete the online evaluation. 

 
Technical Requirements:  Ability to view mp4 video and sound, ability to view and/or download Adobe PDF documents.  Works on most computers, smart phones, tablets, and other connected devices. 

 

 

 

Objectives

  • Describe the new atypical antipsychotics available in the US.
  • Describe new evidence in treating first episode schizophrenia.
  • Describe new evidence supporting augmentation strategies in treatment-resistant schizophrenia.

Speaker(s)/Author(s)

Troy Moore PharmD, MS Pharm, BCPP picture

Troy Moore PharmD, MS Pharm, BCPP
Clinical Pharmacy Specialist – Psychiatry Director, ASHP-Accredited PGY-2 Psychiatric Pharmacy Residency Program Co-Director, Interprofessional Advanced Fellowship in Addiction Treatment, South Texas Veterans Health Care System

Activity Number

0067-0000-16-054-H01-P

Release Date: Apr 1, 2017
Credit Expiration Date: Mar 3, 2019

CE Hours

1.00